Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	6.79	1.18	2.75	28.9	20.8
Short-Term Investments	-	25	25	-	-
Trading Asset Securities	-	8.73	3.91	1.19	2.48
Cash & Short-Term Investments	6.79	34.91	31.66	30.09	23.28
Cash Growth	-80.56%	10.26%	5.22%	29.25%	94.62%
Accounts Receivable	181.37	0.13	1.9	12.32	13.81
Other Receivables	-	2.83	3.66	3.89	4.76
Receivables	181.37	2.97	6.34	20.38	42.22
Inventory	8.43	3.21	4.29	8.77	6.78
Prepaid Expenses	-	0.01	0.13	0.08	0.02
Other Current Assets	72.74	0.2	-	-0	1
Total Current Assets	269.33	41.3	42.43	59.31	73.3
Property, Plant & Equipment	1.86	1.18	1.74	4.55	16.2
Long-Term Investments	0.43	30.64	27.75	4.22	3.9
Other Intangible Assets	-	0	0	0.11	0.32
Long-Term Deferred Tax Assets	0.45	0.54	0.65	0.66	-
Other Long-Term Assets	-	0	-	18.54	2
Total Assets	272.06	73.65	72.57	87.38	95.73
Accounts Payable	93.01	0.03	0.54	8.83	21.46
Accrued Expenses	-	0.07	0.07	0.09	0.13
Current Portion of Long-Term Debt	-	-	-	0.34	-
Other Current Liabilities	3.66	0	0.01	0.05	0.16
Total Current Liabilities	96.67	0.1	0.62	9.29	21.75
Long-Term Debt	-	-	-	1.31	-
Long-Term Deferred Tax Liabilities	-	-	-	-	0.33
Other Long-Term Liabilities	-0	-	-	-	-
Total Liabilities	96.67	0.1	0.62	10.6	22.08
Common Stock	99.5	81	81	81	81
Additional Paid-In Capital	-	12.15	12.15	12.15	12.15
Retained Earnings	-	-24.14	-24.32	-22.74	-28.14
Comprehensive Income & Other	75.89	4.54	3.12	3.63	3.63
Total Common Equity	175.39	73.55	71.95	74.04	68.65
Minority Interest	-	-	-	2.74	5.01
Shareholders' Equity	175.39	73.55	71.95	76.78	73.65
Total Liabilities & Equity	272.06	73.65	72.57	87.38	95.73
Total Debt	-	-	-	1.65	-
Net Cash (Debt)	6.79	34.91	31.66	28.44	23.28
Net Cash Growth	-80.56%	10.26%	11.31%	22.18%	442.70%
Net Cash Per Share	0.68	4.31	3.91	3.51	2.87
Filing Date Shares Outstanding	9.97	8.1	8.1	8.1	8.1
Total Common Shares Outstanding	9.97	8.1	8.1	8.1	8.1
Working Capital	172.66	41.2	41.81	50.02	51.55
Book Value Per Share	17.59	9.08	8.88	9.14	8.47
Tangible Book Value	175.39	73.55	71.95	73.93	68.32
Tangible Book Value Per Share	17.59	9.08	8.88	9.13	8.43
Buildings	-	1.43	1.43	1.43	-
Machinery	-	11.85	12.04	14.54	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.